drugset / Trial / NCT07561398

Comparison of Topical Insulin and Amniotic Membrane Transplant for Persistent Corneal Epithelial Defects

NCT07561398

Phase 4 Recruiting 214 enrolled Al-Shifa Trust Eye Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

After an initial period of standard treatment, they received further care aimed at helping the surface of the eye heal. Clear instructions were given on how to use and store the treatment properly. Patients were then monitored regularly over several months, with doctors checking their healing progress during follow-up visits. The study continued for a total of 24 weeks to observe how well and how quickly the eye surface recovered.

Timeline

Start
2026-03-27
Primary completion
2026-09-27
Completion
2026-09-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Protein / enzyme biologic Topical

Indications